Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating on safety, tolerability, and efficacy of A197 in subjects with Dry Eye Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• A197

Snippet

Sponsor: Aramis Biosciences, Inc. | Conditions: Dry Eye Disease | Phase 2 | Status: COMPLETED